Manuel Aivado

Proteomic identification of interleukin-2 therapy response in metastatic renal cell cancer.

Dimitrios Spentzos, Jon Jones, Handan Can, 2005, The Journal of urology.

Essential role of Jun family transcription factors in PU.1 knockdown–induced leukemic stem cells

Christian Steidl, Daniel G Tenen, Frank Rosenbauer, 2006, Nature Genetics.

Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease

Gil Alterovitz, Xiao-Ying Meng, Rainer Haas, 2007, Proceedings of the National Academy of Sciences.

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

J. Bussel, M. Arning, M. Aivado, 2011, The Lancet.

Serum Protein Profiling with Mass Spectrometry for the Diagnosis of Myelodysplastic Syndromes.

Gil Alterovitz, Xiao-Ying Meng, Hasan H. Otu, 2004 .